Waters Corporation (WAT)
$
354.59
-3.77 (-1.06%)
Key metrics
Financial statements
Free cash flow per share
10.4180
Market cap
21.1 Billion
Price to sales ratio
7.0733
Debt to equity
0.7829
Current ratio
1.8106
Income quality
1.1549
Average inventory
494.4 Million
ROE
0.3861
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Waters Corporation, a recognized name in the specialty measurement field, is known for providing analytical workflow solutions across Asia, the Americas, and Europe. The company operates through two main segments, Waters and TA, focusing on the design, manufacturing, selling, and servicing of high and ultra-performance liquid chromatography and mass spectrometry (MS) technology systems. The company also offers essential support products, including chromatography columns and post-warranty service plans, reflecting its comprehensive service capabilities. The cost of revenue for the company is $747,920,000.00 showcasing its production and operational expenses. Moreover, the company reported selling, general, and administrative expenses of $690,148,000.00 indicating its operational overhead costs. The EBITDA is $1,036,370,000.00 a key indicator of the company's operational profitability. Furthermore, the company incurred an income tax expense of $117,034,000.00 indicating its tax obligations. The weighted average number of diluted shares outstanding is 59,552,000.00 reflecting potential dilution effects associated with its equity structure. Waters Corporation also designs and manufactures instruments for thermal analysis, rheometry, and calorimetry, serving diverse applications in evaluating the stability and suitability of various materials across industries. The stock is priced at $354.59 positioning it in the higher-end market. With a mid-range market capitalization of $21,101,331,769.00 the company is a steady performer. However, the stock has a low average trading volume of 554,998.00 indicating lower market activity. It is a key player in the Medical - Diagnostics & Research industry, contributing significantly to the overall market landscape. Additionally, it belongs to the Healthcare sector, driving innovation and growth. Waters Corporation’s instrumental role in life science, pharmaceutical, environmental, and industrial applications underscores its importance and wide-ranging impact in the global market. By continuously advancing technologies and methodologies, the company is well-positioned to meet the evolving demands of its diverse customer base, which includes researchers in academia, government, and various industries engaged in quality assurance and laboratory applications.
Is Waters Corporation (WAT) a good investment?
Investing in Waters Corporation (WAT) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as B, with a Bullish outlook. Always conduct your own research before investing.
What is Waters Corporation (WAT)'s stock forecast?
Analysts predict Waters Corporation stock to fluctuate between $279.24 (low) and $423.56 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is Waters Corporation's market capitalization?
As of 2025-05-28, Waters Corporation's market cap is $21,101,331,769, based on 59,509,100 outstanding shares.
How does Waters Corporation compare to competitors like Eli Lilly & Co.?
Compared to Eli Lilly & Co., Waters Corporation has a Lower Market-Cap, indicating a difference in performance.
Does Waters Corporation pay dividends?
Waters Corporation pays dividends. The current dividend yield is 0.59%, with a payout of $0.16 per share.
How can I buy Waters Corporation (WAT) stock?
To buy Waters Corporation (WAT) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for WAT. Place an order (Market, Limit, etc.).
What is the best time to invest in Waters Corporation?
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
Has Waters Corporation stock ever split?
Waters Corporation's last stock split was 2:1 on 2000-08-28.
How did Waters Corporation perform in the last earnings report?
Revenue: $2,958,387,000 | EPS: $10.75 | Growth: -1.10%.
Where can I find Waters Corporation's investor relations reports?
Visit https://www.waters.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for Waters Corporation?
You can explore historical data from here
What is the all-time high and low for Waters Corporation stock?
All-time high: $428.22 (2021-09-08) | All-time low: $231.90 (2023-10-25).
What are the key trends affecting Waters Corporation stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
zacks.com
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
reuters.com
U.S.-based Waters Corp , which makes medical equipment used in clinical testing, has seen a spurt in demand from drugmakers in India rushing to develop their versions of popular weight-loss drugs, a senior executive told Reuters.
zacks.com
WAT's first-quarter 2025 results reflect strong growth in the instruments and chemical segments, coupled with strong momentum in the industrial and pharma sectors.
prnewswire.com
News Summary Saves up to six months on compliant software validation in biopharmaceutical quality control.1 Reduces analysis time for biotherapeutic peptides and proteins by 20%.2 Enhances quality control by providing absolute molecular weight of biologics and avoiding common errors encountered with other techniques.3 MILFORD, Mass. , May 6, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today announced that its Empower™ Software now supports biologics data acquisition and quality control (QC) analysis from Multi-Angle Light Scattering (MALS) and differential Refractive Index (RI) instruments in its Wyatt Technology™ Portfolio.
prnewswire.com
Highlights Strong start to the year as first quarter 2025 sales of $662 million landed at the high-end of guidance range; grew 4% as reported and 7% in constant currency Results led by instrument growth of 11% in constant currency, driven by strong momentum in Pharma and Industrial end markets Earnings landed at the high-end of guidance range with GAAP EPS of $2.03 and non-GAAP EPS of $2.25 Raising full-year constant currency sales growth guidance to +5.0% to +7.0%, given first quarter strength Raising full-year non-GAAP EPS guidance to the range of $12.75 to $13.05, net of tariff impact, operational actions, and improvement in FX First Quarter 2025 MILFORD, Mass. , May 6, 2025 /PRNewswire/ -- Waters Corporation (NYSE: WAT), today announced its financial results for the first quarter of 2025.
fool.com
Investors may suddenly feel confused about Carnival (CCL 4.91%) stock. Both Carnival and its largest competitors, Royal Caribbean and Norwegian Cruise Line Holdings, had previously stuck to bullish forecasts as bookings remained strong despite sluggishness in the market.
seekingalpha.com
Initiated positions in Waters Corporation, Penumbra, McKesson, Masimo, and added to UnitedHealth Group due to strong market positions and growth potential. Waters Corporation's growth driven by biopharmaceutical quality control, new regulations, and product replacement cycles, targeting high single to low double-digit revenue growth. Penumbra's mechanical thrombectomy devices target underpenetrated markets with potential FDA approval for Thunderbolt device as a growth catalyst.
zacks.com
Waters (WAT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
prnewswire.com
MILFORD, Mass. , April 8, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q1 2025 financial results conference call on Tuesday, May 6th, 2025 at 8:00 a.m.
zacks.com
BP and SOCAR secure offshore gas licenses in Israel, a strategic move as Israel strengthens its role in the global energy market and expands natural gas exports.
See all news
